BriaCell Therapeutics Corp.
BCTXW · NASDAQ
7/31/2025 | 7/31/2024 | 7/31/2023 | 7/31/2022 | |
|---|---|---|---|---|
| Market Cap | $4 | $169 | $1,368 | $1,298 |
| - Cash | $10 | $1 | $21 | $41 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$6 | $169 | $1,347 | $1,257 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$37 | -$0 | -$27 | -$34 |
| % Margin | – | – | – | – |
| Net Income | -$36 | -$0 | -$20 | -$12 |
| % Margin | – | – | – | – |
| EPS Diluted | -86.25 | -4.28 | -19.79 | -25.7 |
| % Growth | -1,915.2% | 78.4% | 23% | – |
| Operating Cash Flow | -$28 | -$24 | -$24 | -$12 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$28 | -$25 | -$24 | -$12 |